Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-18

Clinical Trial Update: Tranexamic Acid With Microneedling in Melasma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating tranexamic acid with microneedling for melasma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Zagazig University | Conditions: Melasma | Phase 2 | Status: UNKNOWN